ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

YS YS Biopharma Company Ltd

1,02
0,00 (0,00%)
31 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
YS Biopharma Company Ltd YS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,02 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,02 1,02
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.5.202413:30PRNUSYS Biopharma Announces Name Change to LakeShore Biopharma
21.5.202422:15PRNUSYS Biopharma Announces Results of Extraordinary General..
07.5.202422:20PRNUSYS Biopharma to Hold Extraordinary General Meeting on May..
29.4.202414:00PRNUSYS Biopharma Receives Additional 180 Day Extension by Nasdaq..
19.4.202413:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
18.4.202414:00PRNUSYS Biopharma Granted Phase I Clinical Trial License of..
16.4.202414:00PRNUSYS Biopharma to Report First Nine Months of Fiscal Year 2024..
09.4.202414:00PRNUSYS Biopharma Announces Positive Interim Results of Pivotal..
03.4.202414:00PRNUSYS Biopharma Announces Full Repayment of US$40,000,000 Loan..
05.3.202414:00PRNUSYS Biopharma Announces Board Changes and Strategic..
22.2.202423:00PRNUSYS Biopharma Announces Results of Extraordinary General..
18.2.202410:30PRNUS/C O R R E C T I O N -- YS Biopharma Co., Ltd./
17.2.202402:20PRNUSYS Biopharma Announces Results of Extraordinary General..
14.2.202414:00PRNUSYS Biopharma to Hold an Extraordinary General Meeting on..
14.2.202413:50PRNUSYS Biopharma Announces Appointment of New Directors
12.2.202414:50PRNUSYS Biopharma Responds to a Notice of Extraordinary General..
09.2.202412:30PRNUSYS Biopharma Announces US$40 Million Private Placement..
09.2.202400:10PRNUSShareholders of YS Biopharma Announce an Extraordinary..
22.1.202423:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
08.1.202414:00PRNUSYS Biopharma Announces Changes to its Board Committees
20.12.202322:30PRNUSYS Biopharma Responds to Unauthorized Press Release..
20.12.202314:56PRNUSYS Biopharma Co., Ltd. to Hold Extraordinary General Meeting..
14.11.202314:30PRNUSNoble Capital Markets Initiates Coverage on YS Biopharma..
31.10.202313:30PRNUSYS Biopharma Announces Completion of Subject Enrollment in..
26.10.202314:30PRNUSYS Biopharma Announces Receipt of Nasdaq Notice
26.9.202314:30PRNUSYS Biopharma Announces First Subject Enrollment in Pivotal..
15.9.202314:30PRNUSYS Biopharma Granted Patent in the U.S. for Immunotherapy..
05.9.202314:30PRNUSYS Biopharma to Participate in Participate in Citi's 18th..
24.8.202322:15PRNUSYS Biopharma Announces Purchase of Shares by Company..
15.8.202323:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
26.7.202323:00PRNUSYS Biopharma Announces Financial Results for Fiscal Year..
21.7.202322:30PRNUSYS Biopharma to Report Financial Results for Fiscal Year..

Kürzlich von Ihnen besucht